The most overbought stocks in the industrials sector presents an opportunity to go short on these overvalued companies.

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70.

Here’s the latest list of major overbought players in this sector.

Quad/Graphics, Inc. (NYSE:QUAD)

• Quad/Graphics posted an increase in quarterly earnings. Joel Quadracci, Chairman, President & CEO of Quad, said, "We continue to experience positive momentum and top-line growth, achieving a 3% increase in Net Sales in the first quarter of 2023 due to higher sales in our print product and Agency Solutions offerings.” The company’s stock has a 52-week high of $5.39. .
• RSI Value: 71.05
• QUAD Price Action: Shares of Quad/Graphics fell 1.4% to close at $4.28 on Monday.

Enovix Corporation (NASDAQ:ENVX)

• Enovix announced it received a purchase order to produce battery cells for the U.S. Army. "Our cells provide a significant energy density advantage compared to other cells on the market today, and I'm proud that our team has successfully designed and produced BrakeFlow-enabled custom cells for Inventus Power and the U.S. Army," said Raj Talluri, president and CEO of Enovix. The company’s stock has a 52-week high of $26.30.
• RSI Value: 73.64
• ENVX Price Action: Shares of Enovix gained 5.7% to close at $19.80 on Monday.

CIRCOR International, Inc. (NYSE:CIR)

• Private equity firm Arcline Investment Management LP submitted a binding proposal to acquire 100% of the shares of CIRCOR International for $57 per share. The company has a 52-week high of $56.48.
• RSI Value: 89.32
• CIR Price Action: Shares of CIRCOR International fell 0.2% to close at $56.00 on Monday.

CACI International Inc (NYSE:CACI)

Matthews International Corporation (NASDAQ:MATW)

Read More: $4.7M Bet On Black Diamond Therapeutics? Check Out These 3 Stocks Insiders Are Buying